| 2.67 0 (0%) | 02-27 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 3.3 | 1-year : | 3.86 |
| Resists | First : | 2.82 | Second : | 3.3 |
| Pivot price | 2.66  |
|||
| Supports | First : | 2.56 | Second : | 2.4 |
| MAs | MA(5) : | 2.69 |
MA(20) : | 2.63 |
| MA(100) : | 2.6 |
MA(250) : | 2.3 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 67.3 |
D(3) : | 79 |
| RSI | RSI(14): 50.6 |
|||
| 52-week | High : | 3.43 | Low : | 1.6 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ CRON ] has closed below upper band by 47.7%. Bollinger Bands are 46.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 1 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 2.71 - 2.73 | 2.73 - 2.74 |
| Low: | 2.51 - 2.52 | 2.52 - 2.54 |
| Close: | 2.65 - 2.67 | 2.67 - 2.7 |
Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, edibles, concentrates, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under adult-use brands, Spinach. It also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.
Sat, 28 Feb 2026
How The Cronos Group (TSX:CRON) Story Is Shifting With New Targets And Execution Risks - Yahoo Finance
Fri, 27 Feb 2026
Cronos Group Inc. (NASDAQ:CRON) Q4 2025 Earnings Call Transcript - Insider Monkey
Fri, 27 Feb 2026
Decoding Cronos Group Inc (CRON): A Strategic SWOT Insight - GuruFocus
Thu, 26 Feb 2026
Cronos Group (CRON) officer Jared Kenost reports RSU and share holdings - Stock Titan
Thu, 26 Feb 2026
Earnings Call Summary | Cronos Group Inc(CRON.CA) Q4 2025 Earnings Conference - 富途牛牛
Thu, 26 Feb 2026
Earnings call transcript: Cronos Group Q4 2025 sees revenue miss, stock down - Investing.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Outperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 383 (M) |
| Shares Float | 202 (M) |
| Held by Insiders | 47.4 (%) |
| Held by Institutions | 16.2 (%) |
| Shares Short | 3,490 (K) |
| Shares Short P.Month | 4,260 (K) |
| EPS | 0.1 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.82 |
| Profit Margin | 27.2 % |
| Operating Margin | -13.9 % |
| Return on Assets (ttm) | -1.4 % |
| Return on Equity (ttm) | 3.6 % |
| Qtrly Rev. Growth | 6 % |
| Gross Profit (p.s.) | 0.13 |
| Sales Per Share | 0.34 |
| EBITDA (p.s.) | -0.04 |
| Qtrly Earnings Growth | 238.8 % |
| Operating Cash Flow | 22 (M) |
| Levered Free Cash Flow | -22 (M) |
| PE Ratio | 24.22 |
| PEG Ratio | 0 |
| Price to Book value | 0.94 |
| Price to Sales | 7.7 |
| Price to Cash Flow | 46.91 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|